Olaf Burkhardt
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Resistance in Bacteria 17
-
- Antibiotic Use and Resistance 5
- Co-authors
- Tobias WelteHartmut DerendorfMathias W. PletzH. LodeStephan SchmidtA de RouxJan T. KielsteinVolkhard Kaever
- Journals
- Journal of Antimicrobial Chemotherapy (5 papers)Antimicrobial Agents and Chemotherapy (4 papers)Clinical Infectious Diseases (3 papers)European Respiratory Journal (3 papers)Nephrology Dialysis Transplantation (3 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Olaf Burkhardt
55 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 105
- Applied Microbiology and Biotechnology 266
- Molecular Medicine 390
- Critical Care and Intensive Care Medicine 282
- Pharmacology 728
- Clinical Biochemistry 221
Countries citing papers authored by Olaf Burkhardt
This map shows the geographic impact of Olaf Burkhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olaf Burkhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olaf Burkhardt more than expected).
Fields of papers citing papers by Olaf Burkhardt
This network shows the impact of papers produced by Olaf Burkhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olaf Burkhardt. The network helps show where Olaf Burkhardt may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Olaf Burkhardt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 72 | |
| 2 | 2012 | 35 | |
| 3 | 2011 | 19 | |
| 4 | 2011 | 43 | |
| 5 | 2010 | 45 | |
| 6 | 2009 | 63 | |
| 7 | 2009 | 14 | |
| 8 | 2009 | 122 | |
| 9 | 2008 | 10 | |
| 10 | 2007 | 38 | |
| 11 | 2007 | 19 | |
| 12 | 2006 | 76 | |
| 13 | 2006 | 17 | |
| 14 | 2006 | 9 | |
| 15 | 2005 | 41 | |
| 16 | 2005 | 23 | |
| 17 | 2004 | 6 | |
| 18 | 2003 | 3 | |
| 19 | 2003 | 30 | |
| 20 | 2002 | 3 |
About Olaf Burkhardt
Olaf Burkhardt is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Pharmacology, Critical Care and Intensive Care Medicine and Clinical Biochemistry, having authored 56 papers that have together received 2.1k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (26 papers), Antibiotic Resistance in Bacteria (17 papers), Pneumonia and Respiratory Infections (16 papers), Antimicrobial Resistance in Staphylococcus (8 papers), Bacterial Identification and Susceptibility Testing (7 papers), Nosocomial Infections in ICU (6 papers), Sepsis Diagnosis and Treatment (6 papers) and Antibiotic Use and Resistance (5 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (266 citations), Molecular Medicine (390 citations), Critical Care and Intensive Care Medicine (282 citations), Pharmacology (728 citations) and Clinical Biochemistry (221 citations). Olaf Burkhardt has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Tobias Welte, Hartmut Derendorf, Mathias W. Pletz, H. Lode, Stephan Schmidt, A de Roux, Jan T. Kielstein, Volkhard Kaever, Vipul Kumar and Bernd Drewelow. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, Clinical Infectious Diseases, European Respiratory Journal and Nephrology Dialysis Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.